サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1701836

酒さ治療市場レポート：タイプ別、薬剤クラス別、投与経路別、流通チャネル別、エンドユーザー別、地域別、2025年～2033年

Rosacea Treatment Market Report by Type, Drug Class, Route of Administration, Distribution Channel, End User, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 142 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
酒さ治療市場レポート：タイプ別、薬剤クラス別、投与経路別、流通チャネル別、エンドユーザー別、地域別、2025年～2033年
出版日: 2025年04月01日
発行: IMARC
ページ情報: 英文 142 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

酒さ治療市場の世界市場規模は2024年に21億米ドルに達しました。今後、IMARC Groupは、市場は2033年までに33億米ドルに達し、2025年から2033年にかけて5.3％の成長率（CAGR）を示すと予測しています。内服治療に対する需要の高まりと製薬業界の拡大が主に市場を牽引しています。

酒さ治療とは、血管を拡張し赤みを引き起こす慢性皮膚病を治すために採用される予防策を指します。これには、抗生物質、α作動薬、レチノイド、コルチコステロイド、免疫抑制剤、降圧剤などの内服薬や外用薬が含まれます。重症例では、肥厚した皮膚の除去、組織の縮小、鼻茸の治療を目的として、強力パルス光治療、レーザー治療、美容外科手術が行われます。酒さ治療は、一般的に鼻、頬、胸、耳、背中、額などに生じる皮膚の炎症、発赤、目の炎症、膿を持った隆起などの症状を緩和するのに役立ちます。また、皮膚の変色を抑え、乾燥、かゆみ、目のかすみ、光に対する過敏症を改善します。

酒さ治療市場傾向：

過度の温度変化、運動、化粧品や医薬品の用途の増加、辛い食事、熱い飲み物、アルコールの広範な消費による酒さの有病率の増加は、市場成長を促進する主な要因の1つです。さらに、赤み、にきび、吹き出物、細菌の炎症を抑えるためのシロップ、錠剤、カプセル、液体などの経口治療に対する需要の増加が、市場成長にかなりの弾みをつけています。さらに、自然な白色光と解像度で撮影したデジタル画像を利用して顔の病変や症状を特定し、酒さになりやすい部位を認識する人工知能（AI）搭載の診断ツールの導入が、市場に明るい見通しをもたらしています。さらに、初期の顕著な症状を軽減し、内服治療中止時の再発を予防し、長期的なコントロールを維持するための併用治療の採用が増加していることが、市場成長に弾みをつけています。その他の要因としては、研究開発（R&D）活動を促進するための複数の政府による取り組みや投資の増加、消費者の支出能力の上昇、治療効率を高めるための製薬企業による新しいジェネリック医薬品の発売、早期診断と効果的な治療オプションに対する意識の高まりなどが挙げられ、市場成長の原動力になると予想されます。

本レポートで扱う主な質問

  • 2024年の世界の酒さ治療市場の市場規模は？
  • 2025-2033年の世界の酒さ治療市場の予想成長率は？
  • 世界の酒さ治療市場を牽引する主要因は何か？
  • 世界の酒さ治療の市場成長に対するCOVID-19の影響は？
  • 世界の酒さ治療市場の薬剤クラス別構成比は？
  • 世界の酒さ治療市場における投与経路別の内訳は？
  • 世界の酒さ治療市場における主要地域は？
  • 世界の酒さ治療市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の酒さ治療市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：タイプ別

  • 紅斑毛細血管拡張性酒さ
  • 丘疹膿疱性酒さ
  • 眼性酒さ
  • フィマトス酒さ

第7章 市場内訳：薬剤クラス別

  • 抗生物質
  • アルファ作動薬
  • レチノイド
  • コルチコステロイド
  • 免疫抑制剤
  • 降圧剤
  • その他

第8章 市場内訳：投与経路別

  • 局所
  • 経口

第9章 市場内訳：流通チャネル別

  • 病院薬局
  • オンライン薬局
  • 小売薬局
  • その他

第10章 市場内訳：エンドユーザー別

  • 病院
  • ホームケア
  • 専門クリニック
  • その他

第11章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場内訳：国別

第12章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第13章 バリューチェーン分析

第14章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第15章 価格分析

第16章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Bausch Health Companies Inc.
    • Cellix Bio Private Limited
    • Colorescience Inc.
    • Croda International Plc
    • Galderma S.A.
    • LEO Pharma A/S
    • Lupin Limited
    • Maruho Co. Ltd.
    • PruGen Pharmaceuticals
    • Sol-Gel Technologies Ltd.
    • Timber Pharmaceuticals LLC
図表

List of Figures

  • Figure 1: Global: Rosacea Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Rosacea Treatment Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Rosacea Treatment Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Rosacea Treatment Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Rosacea Treatment Market: Breakup by Drug Class (in %), 2024
  • Figure 6: Global: Rosacea Treatment Market: Breakup by Route of Administration (in %), 2024
  • Figure 7: Global: Rosacea Treatment Market: Breakup by Distribution Channel (in %), 2024
  • Figure 8: Global: Rosacea Treatment Market: Breakup by End User (in %), 2024
  • Figure 9: Global: Rosacea Treatment Market: Breakup by Region (in %), 2024
  • Figure 10: Global: Rosacea Treatment (Erythematotelangiectatic Rosacea) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Rosacea Treatment (Erythematotelangiectatic Rosacea) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Rosacea Treatment (Papulopustular Rosacea) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Rosacea Treatment (Papulopustular Rosacea) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Rosacea Treatment (Ocular Rosacea) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Rosacea Treatment (Ocular Rosacea) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Rosacea Treatment (Phymatous Rosacea) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Rosacea Treatment (Phymatous Rosacea) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Rosacea Treatment (Antibiotics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Rosacea Treatment (Antibiotics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Rosacea Treatment (Alpha Agonists) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Rosacea Treatment (Alpha Agonists) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Rosacea Treatment (Retinoids) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Rosacea Treatment (Retinoids) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Rosacea Treatment (Corticosteroids) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Rosacea Treatment (Corticosteroids) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Rosacea Treatment (Immunosuppressants) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Rosacea Treatment (Immunosuppressants) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Rosacea Treatment (Antihypertensive Agents) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Rosacea Treatment (Antihypertensive Agents) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Rosacea Treatment (Other Drug Classes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Rosacea Treatment (Other Drug Classes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Rosacea Treatment (Topical) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Rosacea Treatment (Topical) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Global: Rosacea Treatment (Oral) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Global: Rosacea Treatment (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Global: Rosacea Treatment (Hospital Pharmacy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Global: Rosacea Treatment (Hospital Pharmacy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Global: Rosacea Treatment (Online Pharmacy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Global: Rosacea Treatment (Online Pharmacy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Global: Rosacea Treatment (Retail Pharmacy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Global: Rosacea Treatment (Retail Pharmacy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Global: Rosacea Treatment (Other Distribution Channels) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Global: Rosacea Treatment (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Global: Rosacea Treatment (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Global: Rosacea Treatment (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Global: Rosacea Treatment (Homecare) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Global: Rosacea Treatment (Homecare) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Global: Rosacea Treatment (Specialty Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Global: Rosacea Treatment (Specialty Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Global: Rosacea Treatment (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Global: Rosacea Treatment (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: North America: Rosacea Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: North America: Rosacea Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: United States: Rosacea Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: United States: Rosacea Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Canada: Rosacea Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Canada: Rosacea Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Asia-Pacific: Rosacea Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Asia-Pacific: Rosacea Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: China: Rosacea Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: China: Rosacea Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Japan: Rosacea Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Japan: Rosacea Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: India: Rosacea Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: India: Rosacea Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: South Korea: Rosacea Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: South Korea: Rosacea Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Australia: Rosacea Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Australia: Rosacea Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Indonesia: Rosacea Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Indonesia: Rosacea Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Others: Rosacea Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Others: Rosacea Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Europe: Rosacea Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Europe: Rosacea Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Germany: Rosacea Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Germany: Rosacea Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: France: Rosacea Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: France: Rosacea Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: United Kingdom: Rosacea Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: United Kingdom: Rosacea Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Italy: Rosacea Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 83: Italy: Rosacea Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 84: Spain: Rosacea Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 85: Spain: Rosacea Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 86: Russia: Rosacea Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 87: Russia: Rosacea Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 88: Others: Rosacea Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 89: Others: Rosacea Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 90: Latin America: Rosacea Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 91: Latin America: Rosacea Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 92: Brazil: Rosacea Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 93: Brazil: Rosacea Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 94: Mexico: Rosacea Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 95: Mexico: Rosacea Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 96: Others: Rosacea Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 97: Others: Rosacea Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 98: Middle East and Africa: Rosacea Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 99: Middle East and Africa: Rosacea Treatment Market: Breakup by Country (in %), 2024
  • Figure 100: Middle East and Africa: Rosacea Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 101: Global: Rosacea Treatment Industry: SWOT Analysis
  • Figure 102: Global: Rosacea Treatment Industry: Value Chain Analysis
  • Figure 103: Global: Rosacea Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Rosacea Treatment Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Rosacea Treatment Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Rosacea Treatment Market Forecast: Breakup by Drug Class (in Million USD), 2025-2033
  • Table 4: Global: Rosacea Treatment Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
  • Table 5: Global: Rosacea Treatment Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 6: Global: Rosacea Treatment Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 7: Global: Rosacea Treatment Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 8: Global: Rosacea Treatment Market: Competitive Structure
  • Table 9: Global: Rosacea Treatment Market: Key Players
目次
Product Code: SR112025A6569

The global rosacea treatment market size reached USD 2.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.3 Billion by 2033, exhibiting a growth rate (CAGR) of 5.3% during 2025-2033. The rising demand for oral treatments and the expanding pharmaceutical industry are primarily driving the market.

Rosacea treatment refers to preventive measures adopted to cure a chronic skin disease that enlarges blood vessels and causes redness. It includes oral and topical medications, such as antibiotics, alpha agonists, retinoids, corticosteroids, immunosuppressants, and antihypertensive agents. In severe cases, intense pulsed light therapy, laser treatment, and cosmetic surgery are used to remove thickened skin, shrink tissues, and treat rhinophyma. Rosacea treatment assists in easing the symptoms, such as skin inflammation, redness, inflamed eyes, and puss-filled bumps that generally occur on the nose, cheeks, chest, ear, back, and forehead. It also reduces skin discoloration and improves dryness, itching, blurred vision, and sensitivity to light.

Rosacea Treatment Market Trends:

The increasing prevalence of rosacea due to excessive temperature changes, exercise, rising application of cosmetics, pharmaceuticals, and widespread consumption of spicy meals, hot drinks, and alcohol is one of the key factors driving the market growth. Furthermore, increasing demand for oral treatments, such as syrups, tablets, capsules, and liquids, to reduce redness, acne, pimples, and bacterial inflammation, is providing a considerable boost to the market growth. Additionally, the introduction of artificial intelligence (AI)-powered diagnostic tools that utilize digital image shots in natural white light and resolutions to identify facial lesions and symptoms and recognize areas prone to rosacea is creating a positive outlook for the market. Moreover, increasing adoption of combination treatments to reduce initial prominent symptoms, prevent relapse on discontinuation of oral therapy, and maintain long-term control is providing an impetus to the market growth. Other factors, including increasing initiatives and investments by several governments to promote research and development (R&D) activities, rising expenditure capacities of consumers, the launch of new generic products by pharmaceutical companies to increase the efficiency of the treatment, and growing awareness of early diagnosis and effective treatment options, are anticipated to drive market growth.

Key Market Segmentation:

Breakup by Type:

  • Erythematotelangiectatic Rosacea
  • Papulopustular Rosacea
  • Ocular Rosacea
  • Phymatous Rosacea

Breakup by Drug Class:

  • Antibiotics
  • Alpha Agonists
  • Retinoids
  • Corticosteroids
  • Immunosuppressants
  • Antihypertensive Agents
  • Others

Breakup by Route of Administration:

  • Topical
  • Oral

Breakup by Distribution Channel:

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy
  • Others

Breakup by End User:

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Bausch Health Companies Inc., Cellix Bio Private Limited, Colorescience Inc., Croda International Plc, Galderma S.A., LEO Pharma A/S, Lupin Limited, Maruho Co. Ltd., PruGen Pharmaceuticals, Sol-Gel Technologies Ltd. and Timber Pharmaceuticals LLC.

Key Questions Answered in This Report

  • 1.What was the size of the global rosacea treatment market in 2024?
  • 2.What is the expected growth rate of the global rosacea treatment market during 2025-2033?
  • 3.What are the key factors driving the global rosacea treatment market?
  • 4.What has been the impact of COVID-19 on the global rosacea treatment market growth?
  • 5.What is the breakup of the global rosacea treatment market based on the drug class?
  • 6.What is the breakup of the global rosacea treatment market based on the route of administration?
  • 7.What are the key regions in the global rosacea treatment market?
  • 8.Who are the key players/companies in the global rosacea treatment market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Rosacea Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Erythematotelangiectatic Rosacea
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Papulopustular Rosacea
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Ocular Rosacea
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Phymatous Rosacea
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Drug Class

  • 7.1 Antibiotics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Alpha Agonists
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Retinoids
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Corticosteroids
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Immunosuppressants
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Antihypertensive Agents
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Others
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast

8 Market Breakup by Route of Administration

  • 8.1 Topical
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Oral
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Hospital Pharmacy
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Online Pharmacy
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Retail Pharmacy
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by End User

  • 10.1 Hospitals
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Homecare
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Specialty Clinics
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Others
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Bausch Health Companies Inc.
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Cellix Bio Private Limited
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
    • 16.3.3 Colorescience Inc.
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
    • 16.3.4 Croda International Plc
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
      • 16.3.4.3 Financials
      • 16.3.4.4 SWOT Analysis
    • 16.3.5 Galderma S.A.
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
    • 16.3.6 LEO Pharma A/S
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
      • 16.3.6.3 SWOT Analysis
    • 16.3.7 Lupin Limited
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
      • 16.3.7.4 SWOT Analysis
    • 16.3.8 Maruho Co. Ltd.
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 SWOT Analysis
    • 16.3.9 PruGen Pharmaceuticals
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
    • 16.3.10 Sol-Gel Technologies Ltd.
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 Financials
    • 16.3.11 Timber Pharmaceuticals LLC
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio